| Particulars |
|
|
|
| Company Name
| Piramal Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
1,329.25 |
B.V. (₹) |
58.30 |
| Sales(₹ Cr.) |
5,285.71 |
NP (₹ Cr.) |
690.16 |
| NP Var% |
78.00 |
Div% |
1.00 |
| CPS(₹) |
6.90 |
EPS (₹) |
5.20 |
| Traded Value(₹ Lakhs) |
296.46 |
52 Week High |
241.00 |
| 52 Week Low |
148.00 |
Price BSE |
166.00 |
| Price NSE |
166.00 |
Market Capital (₹ Cr.) |
22,052.23 |
| P/C Ratio |
24.20 |
P/E Ratio |
32.00 |
| Price Vs.BV |
2.85 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
1,195.81 |
| NP(₹ Cr.) |
151.33 |
NP Var % |
27.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
4,897.03 |
| OPM |
19.33 |
NP |
642.75 |
| NP Var% |
7.40 |
EPS |
5.55 |
| PE |
29.89 |
|
|